New drugs showing promise for CLL patients at ASH 2014: A discussion between Prof John Gribben and Prof Peter Hillmen

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Peter Hillmen (Leeds General Infirmary, UK) about recent advances in the research of chronic lymphocytic leukaemia (CLL) that wer... Author: PatientPowerEU Added: 01/27/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts